New research shows that the number of mitochondria in a cell is associated with drug resistance, which could have a far-reaching impact in cancer treatment.
Alzheimer’s disease, a terminal neurodegenerative disease, has historically been diagnosed based on observing significant memory loss.
The patterning of molecules is critical in applications including microarrays, tissue engineering, biosensors, biomaterials and fundamental cell studies.
IBM’s collaboration with The Michael J. Fox Foundation aims to better understand Parkinson's disease (PD), a chronic, degenerative neurological disorder.
Coronary Artery Disease (CAD) is a condition in which plaque forms on the walls of coronary arteries, causing them to narrow. Eventually, this could lead to a heart attack, or death. This condition is now the single largest health problem in the world, with over one million people in the US undergoing cardiac catheterization – […]
Medical imaging creates tremendous amounts of data: many emergency room radiologists must examine as many as 200 cases each day, and some medical studies contain up to 3,000 images. Each patient’s image collection can contain 250GB of data, ultimately creating collections across organizations that are petabytes in size. Within IBM Research, we see potential in […]
Could you make a critical health policy decision using four-year-old data? Cancer registries hold vital data sets, kept tightly encrypted, containing demographic information, medical history, diagnostics and therapy. Oncologists and health officials access the data to understand the diagnosed cancer cases and incidence rates nationally. The ultimate goal is to use this data to inform […]
One of the largest growing demographics in the EU is individuals aged 65 and over, and two thirds of this group are in situation of multimorbidity, i.e., perons who suffer from two or more chronic diseases. The ineffective treatment of multimorbidity has been pointed out as an urgent problem to address by the Academy of […]
Half of IBM’s 2018 Fellows Hail from IBM Research For more than 70 years, IBM Research has defined the future of technology for IBM. Today, we lead the way forward in AI, blockchain, quantum computing and cybersecurity, thanks to critical foundational research conducted across our global labs. This defining moment in IBM’s transformation is made […]
In 2016, I had a bacterial infection that I acquired after a routine knee surgery. Fortunately, my immune system reacted favorably to antibiotics, but had the bacteria been a “superbug,” resistant to medication, my story might have had a different ending. This incident inspired me to focus my work on discovering a new solution. With […]
Published in Science: IBM and Memorial Sloan Kettering researchers solve cancer immunotherapy mystery
Cancer immunotherapies, treatment approaches which harness a person’s own immune system to target and kill cancer cells, are currently a major driver in the development of new cancer treatments. With the advent of next-generation gene editing technologies like CRISPR-Cas9, one could imagine a future in which cancer treatments are tailor-made not only for particular cancer […]